1.83
+0.02(+1.10%)
Currency In USD
| Previous Close | 1.81 |
| Open | 1.88 |
| Day High | 1.99 |
| Day Low | 1.76 |
| 52-Week High | 9.19 |
| 52-Week Low | 1.76 |
| Volume | 149,917 |
| Average Volume | 157,965 |
| Market Cap | 16.2M |
| PE | -0.85 |
| EPS | -2.16 |
| Moving Average 50 Days | 2.07 |
| Moving Average 200 Days | 2.61 |
| Change | 0.02 |
If you invested $1000 in Daré Bioscience, Inc. (DARE) 10 years ago, it would be worth $4.38 as of November 09, 2025 at a share price of $1.83. Whereas If you bought $1000 worth of Daré Bioscience, Inc. (DARE) shares 5 years ago, it would be worth $148.06 as of November 09, 2025 at a share price of $1.83.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
GlobeNewswire Inc.
Nov 06, 2025 1:00 PM GMT
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real solutions, will host a conference cal
Daré Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
The project underscores Daré Bioscience’s growing role in shaping the future of contraceptive innovationSAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on clo
Daré Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders
GlobeNewswire Inc.
Oct 06, 2025 12:00 PM GMT
Exploring Strategic Partnerships to Expand Platform Beyond Reproductive HealthSAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women's health betw